Considering the current market dynamics and the recent developments reported by Vaxart Inc., I am interested in a technical discussion regarding the outlook on VXRT stock. In light of its ongoing clinical trials and evolving regulatory environment, what are the underlying fundamental catalysts that could drive upward momentum? Additionally, how might technical indicators—such as volume-weighted averages, moving averages, and Relative Strength Index (RSI)—inform potential entry or exit points?
A comprehensive analysis that integrates both fundamental and technical perspectives would be highly valued. Any insights into recent earnings reports, pipeline developments, or macroeconomic factors affecting the biotech sector would be appreciated.